Why the study?
Do sirolimus-eluting stents compared to paclitaxel-eluting stents reduce major adverse cardiac events in patients with coronary lesions?
Do sirolimus-eluting stents compared to paclitaxel-eluting stents reduce major adverse cardiac events in patients with coronary lesions?
In routine clinical practice, there was no significant difference in MACE between sirolimus-eluting and paclitaxel-eluting stents, though stent overlapping independently predicted MACE and TVR.
Answers are grounded in this paper and cite their sources.
Similar MACE rates with SES versus PES in routine practice; leaves open superiority without randomized evidence.
BACKGROUND: We compared two consecutive series of patients treated with sirolimus-eluting stents (SES) or paclitaxel-eluting stents (PES). METHODS: Two hundred and ninety-five patients with 590 coronary lesions were treated with 274 SES and 379 PES. Patients with symptoms or positive dobutamine stress echocardiography were subjected to repeat coronary angiography. RESULTS: During a follow-up of 13.3 +/- 5.7 months, the incidence rate of major adverse cardiac events (MACE) was 4.1%, including, 1 death, 4 Q-wave myocardial infarctions, 2 late angiographic stent thromboses, 3 subacute stent thromboses, and 11 target vessel revascularizations (TVR), and was not significantly different between SES (n = 5) and PES (n = 7). Stent overlapping was found to be an independent predictor of both MACE (odds ratio = 0.078, P = 0.02) and TVR (odds ratio = 0.077, P = 0.02). Follow-up symptoms- or ischemia-driven angiography was performed in 45 patients. Only vessel size was a predictor of stent restenosis (P = 0.02), independent of stent type. Late loss was independently predicted by postdilatation of stent (beta =-0.24, P = 0.03), but not by type of stent (P = 0.14) or other parameters. Edge restenosis was seen in 8 patients subjected to lesion predilatation. The restenosis pattern after SES implantation was focal, but diffuse (n = 1) or proliferative (n = 1) restenosis, and in-stent aneurysm formation (n = 1) was also seen with PES. CONCLUSIONS: Despite a trend for a higher incidence of MACE with PES, no significant differences between the two stent types were detected. Diffuse restenosis was seen only with PES, and edge restenosis only in lesions with balloon predilatation before stent implantation. Stent overlapping was an independent predictor of both TVR and MACE.
No takes yet. Share an insight, caveat, or question.
Katritsis et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: